161 related articles for article (PubMed ID: 36561640)
1. Negative symptom dimensions and social functioning in Chinese patients with schizophrenia.
Gao T; Huang Z; Huang B; Zhou T; Shi C; Yu X; Pu C
Front Psychiatry; 2022; 13():1033166. PubMed ID: 36561640
[TBL] [Abstract][Full Text] [Related]
2. Correlation between the Personal and Social Performance scale (PSP) and the Positive and Negative Syndrome Scale (PANSS) in a Greek sample of patients with schizophrenia.
Jelastopulu E; Giourou E; Merekoulias G; Mestousi A; Moratis E; Alexopoulos EC
BMC Psychiatry; 2014 Jul; 14():197. PubMed ID: 25005616
[TBL] [Abstract][Full Text] [Related]
3. The impact of insight on social functioning in patients with schizophrenia.
Erol A; Delibas H; Bora O; Mete L
Int J Soc Psychiatry; 2015 Jun; 61(4):379-85. PubMed ID: 25182810
[TBL] [Abstract][Full Text] [Related]
4. Negative symptoms and everyday functioning in schizophrenia: a cross-sectional study in a real world-setting.
Rocca P; Montemagni C; Zappia S; Piterà R; Sigaudo M; Bogetto F
Psychiatry Res; 2014 Aug; 218(3):284-9. PubMed ID: 24814140
[TBL] [Abstract][Full Text] [Related]
5. A randomized controlled trial of olanzapine versus haloperidol in the treatment of primary negative symptoms and neurocognitive deficits in schizophrenia.
Lindenmayer JP; Khan A; Iskander A; Abad MT; Parker B
J Clin Psychiatry; 2007 Mar; 68(3):368-79. PubMed ID: 17388705
[TBL] [Abstract][Full Text] [Related]
6. Optimal cutoff scores of the Chinese version of 15-item negative symptom assessment that indicate prominent negative symptoms of schizophrenia.
Zhou Q; Pu CC; Huang BJ; Miao Q; Zhou TH; Cheng Z; Gao TQ; Shi C; Yu X
Front Psychiatry; 2023; 14():1154459. PubMed ID: 37139322
[TBL] [Abstract][Full Text] [Related]
7. Measuring social functioning with the personal and social performance scale in patients with acute symptoms of schizophrenia: interpretation of results of a pooled analysis of three Phase III trials of paliperidone extended-release tablets.
Patrick DL; Burns T; Morosini P; Gagnon DD; Rothman M; Adriaenssen I
Clin Ther; 2010 Feb; 32(2):275-92. PubMed ID: 20206786
[TBL] [Abstract][Full Text] [Related]
8. Relationship between clinical outcomes measures and personal and social performance functioning in a prospective, interventional study in schizophrenia.
Vauth R; Carpiniello B; Turczyński J; Ivanov M; Cherubin P; Lahaye M; Schreiner A
Int J Methods Psychiatr Res; 2021 Jun; 30(2):e1855. PubMed ID: 33355966
[TBL] [Abstract][Full Text] [Related]
9. Is personal and social functioning associated with subjective quality of life in schizophrenia patients living in the community?
Brissos S; Balanzá-Martinez V; Dias VV; Carita AI; Figueira ML
Eur Arch Psychiatry Clin Neurosci; 2011 Oct; 261(7):509-17. PubMed ID: 21384166
[TBL] [Abstract][Full Text] [Related]
10. Validation of the Chinese Version of the 16-Item Negative Symptom Assessment.
Huang BJ; Wang Y; Miao Q; Yu X; Pu CC; Shi C
Neuropsychiatr Dis Treat; 2020; 16():1113-1120. PubMed ID: 32440125
[TBL] [Abstract][Full Text] [Related]
11. Symptom severity is more closely associated with social functioning status in inpatients with schizophrenia than cognitive deficits.
Zuo S; Byrne LK; Peng D; Mellor D; McCabe M; Zhang J; Huang J; Xu Y
Shanghai Arch Psychiatry; 2012 Apr; 24(2):83-90. PubMed ID: 25324608
[TBL] [Abstract][Full Text] [Related]
12. Impact of cognitive performance and negative symptoms on psychosocial functioning in Czech schizophrenia patients.
Kalisova L; Michalec J; Dechterenko F; Silhan P; Hyza M; Chlebovcova M; Brenova M; Bezdicek O
Schizophrenia (Heidelb); 2023 Jul; 9(1):43. PubMed ID: 37460587
[TBL] [Abstract][Full Text] [Related]
13. The longitudinal trends in the relationship between drug-induced extrapyramidal symptoms and personal and social performance in a population of the patients with schizophrenia: A latent growth model.
Park IJ; Jung DC; Hwang SS; Jung HY; Yoon JS; Kim CE; Ahn YM; Kim YS
Psychiatry Res; 2016 Apr; 238():33-39. PubMed ID: 27086208
[TBL] [Abstract][Full Text] [Related]
14. [Negative symptoms predict the improvement of social functioning of patients with schizophrenia].
He Q; Chen Y; Chow SL; Huang MM; Zhang ZQ; Zhang SS; Shen WW; Deng H
Sichuan Da Xue Xue Bao Yi Xue Ban; 2014 Mar; 45(2):284-8. PubMed ID: 24749359
[TBL] [Abstract][Full Text] [Related]
15. Validation of the Personal and Social Performance (PSP) Scale in a German sample of acutely ill patients with schizophrenia.
Juckel G; Schaub D; Fuchs N; Naumann U; Uhl I; Witthaus H; Hargarter L; Bierhoff HW; Brüne M
Schizophr Res; 2008 Sep; 104(1-3):287-93. PubMed ID: 18595665
[TBL] [Abstract][Full Text] [Related]
16. Clinical utility of the Negative Symptom Assessment-16 in individuals with schizophrenia.
Rekhi G; Alphs L; Ang MS; Lee J
Eur Neuropsychopharmacol; 2019 Dec; 29(12):1433-1441. PubMed ID: 31761524
[TBL] [Abstract][Full Text] [Related]
17. A Random Forest Model for Predicting Social Functional Improvement in Chinese Patients with Schizophrenia After 3 Months of Atypical Antipsychotic Monopharmacy: A Cohort Study.
Li Y; Zhang L; Zhang Y; Wen H; Huang J; Shen Y; Li H
Neuropsychiatr Dis Treat; 2021; 17():847-857. PubMed ID: 33776440
[TBL] [Abstract][Full Text] [Related]
18. Reliability, validity and ability to detect change of the clinician-rated Personal and Social Performance scale in patients with acute symptoms of schizophrenia.
Patrick DL; Burns T; Morosini P; Rothman M; Gagnon DD; Wild D; Adriaenssen I
Curr Med Res Opin; 2009 Feb; 25(2):325-38. PubMed ID: 19192977
[TBL] [Abstract][Full Text] [Related]
19. The psychometric properties of the Self-Evaluation of Negative Symptoms Scale (SNS) in treatment-resistant schizophrenia (TRS).
Goldring A; Borne S; Hefner A; Thanju A; Khan A; Lindenmayer JP
Schizophr Res; 2020 Oct; 224():159-166. PubMed ID: 33071071
[TBL] [Abstract][Full Text] [Related]
20. Negative symptoms in schizophrenia, assessed by the brief negative symptom scale, self-evaluation of negative symptom scale, and social cognition: a gender effect.
Wójciak P; Domowicz K; Andrzejewska M; Rybakowski JK
Int J Psychiatry Clin Pract; 2021 Sep; 25(3):252-257. PubMed ID: 32862741
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
